Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of a new branded generic etoricoxib tablet
TCTR20210714009Phase 1Completed
- Sponsor
- N/A
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of etoricoxib in pain, osteoarthritis (OA) and rheumatoid arthritis (RA) (2 arms), sponsored by N/A. Started Feb 2020; status: completed.
02
Drugs
etoricoxib
03
Conditions
painosteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on TCTR20210714009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210714009.